Evidence map›Paper›PMID 18079022›Full record

ArticleNeurochemistry international2008

Amyloid-beta peptide binds to microtubule-associated protein 1B (MAP1B).

Goar Gevorkian, Alfonso Gonzalez-Noriega, Gonzalo Acero, Jorge Ordoñez, Colette Michalak, Maria Elena Munguia, Tzipe Govezensky, David H Cribbs, Karen Manoutcharian

Open access · greenAbstract read
In one paragraph

Article in Neurochemistry international, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule-associated proteins.Developmental dynamics : an official publication of the American Association of Anatomists · 2018
    Review
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Goar GevorkianInstituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de Mexico, Apartado Postal 70228, Cuidad Universitaria, Mexico DF, CP 04510, Mexico. gokar@servidor.unam.mx <gokar@servidor.unam.mx>
Alfonso Gonzalez-Noriega
Gonzalo Acero
Jorge Ordoñez
Colette Michalak
Maria Elena Munguia
Tzipe Govezensky
David H Cribbs
Karen Manoutcharian
Universidad Nacional Autónoma de México · MXUniversity of California, Irvine · US

Funding

Combining AD Epitope Vaccine with Innate ImmunityR01NS050895 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI AGADJANYAN, MICHAEL G, CRIBBS, DAVID HASTINGS · 2004 to 2018
$7.4M
Multiple Approaches to Abeta Vaccination in Animal ModelsR01AG020241 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI AGADJANYAN, MICHAEL G, CRIBBS, DAVID HASTINGS · 2001 to 2016
$5.6M
Multiple Approaches to Abeta Vaccination in Animal ModelsRF1AG020241 · NIA · INSTITUTE FOR MOLECULAR MEDICINE · PI AGADJANYAN, MICHAEL G, CRIBBS, DAVID HASTINGS · 2018 to 2018
$3.3M
AMYLOD BETA-PEPTIDE SPECIFIC scFv ANTIBODIESR21AG023534 · NIA · UNIVERSITY OF MEXICO, UNAM · PI GEVORKIAN, GOAR · 2004 to 2005
$194k
NIA NIH HHS AG 023534NIA NIH HHS AG-20241NIA NIH HHS R01 AG020241NIA NIH HHS R21 AG023534NIA NIH HHS RF1 AG020241NINDS NIH HHS NS-050895NINDS NIH HHS R01 NS050895
6 · The paper itself

Abstract

Extracellular and intraneuronal formation of amyloid-beta aggregates have been demonstrated to be involved in the pathogenesis of Alzheimer's disease. However, the precise mechanism of amyloid-beta neurotoxicity is not completely understood. Previous studies suggest that binding of amyloid-beta to a number of targets have deleterious effects on cellular functions. In the present study we have shown for the first time that amyloid-beta 1-42 bound to a peptide comprising the microtubule binding domain of the heavy chain of microtubule-associated protein 1B by the screening of a human brain cDNA library expressed on M13 phage. This interaction may explain, in part, the loss of neuronal cytoskeletal integrity, impairment of microtubule-dependent transport and synaptic dysfunction observed previously in Alzheimer's disease.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesBrainCell Line, TumorHumansMicrotubule-Associated ProteinsMicrotubulesNeuronsPeptide FragmentsPeptidesProtein BindingProtein Structure, TertiaryProtein TransportSynaptic TransmissionAmyloid beta-Peptidesamyloid beta-protein (1-42)MAP1B protein, humanMicrotubule-Associated ProteinsPeptide FragmentsPeptides

Identifiers

PMID18079022
PMCPMC2390996
OpenAlexW2018024086

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.